Predictive Biomarkers of Response to Nivolumab in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study

被引：0
|
作者：
Kataoka, Y. [1 ]
Hirano, K. [1 ]
Narabayashi, T. [2 ]
Hara, S. [3 ]
Fujimoto, D. [4 ]
Tanaka, T. [5 ]
Ebi, N. [6 ]
Tomii, K. [4 ]
Yoshioka, H. [5 ]
机构：
[1] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan
[2] Jcho Osaka Hosp, Osaka, Japan
[3] Itami City Hosp, Dept Internal Med, Itami, Hyogo, Japan
[4] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan
[5] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
[6] Iizuka Hosp, Dept Resp Med, Iizuka, Fukuoka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
immunotherapy; NSCLC; biomarker;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-004
引用
收藏
页码：S1995 / S1995
页数：1
相关论文
共 50 条
  • [1] Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab
    Costantini, Adrien
    Julie, Catherine
    Dumenil, Coraline
    Helias-Rodzewicz, Zofia
    Tisserand, Julie
    Dumoulin, Jennifer
    Giraud, Violaine
    Labrune, Sylvie
    Chinet, Thierry
    Emile, Jean-Francois
    Leprieur, Etienne Giroux
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [2] Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung Cancer
    Kataoka, Yuki
    Hirano, Katsuya
    Narabayashi, Tomoko
    Hara, Satoshi
    Fujimoto, Daichi
    Tanaka, Tae
    Ebi, Noriyuki
    Tomii, Keisuke
    Yoshioka, Hiroshige
    ANTICANCER RESEARCH, 2018, 38 (01) : 559 - 563
  • [3] Study on Biomarkers for Predictive the Clinical Efficacy of Non-small Cell Lung Cancer Immunotherapy
    Cui, T.
    Tian, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S613 - S613
  • [4] Predictive and Prognostic Biomarkers in Non-Small Cell Lung Cancer
    Thakur, Manish K.
    Gadgeel, Shirish M.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (05) : 760 - 770
  • [5] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [6] The rapidly changing field of predictive biomarkers of non-small cell lung cancer
    Toth, Laszlo Jozsef
    Mokanszki, Attila
    Mehes, Gabor
    PATHOLOGY & ONCOLOGY RESEARCH, 2024, 30
  • [7] An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer
    Ahmadzada, Tamkin
    Kao, Steven
    Reid, Glen
    Boyer, Michael
    Mahar, Annabelle
    Cooper, Wendy A.
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (06)
  • [8] Predictive biomarkers in the treatment of non-small cell lung cancer (NSCLC)
    Niho, Seiji
    CANCER SCIENCE, 2018, 109 : 423 - 423
  • [9] Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
    Sutic, Maja
    Vukic, Ana
    Baranasic, Jurica
    Foersti, Asta
    Dzubur, Feda
    Samarzija, Miroslav
    Jakopovic, Marko
    Brcic, Luka
    Knezevic, Jelena
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (11):
  • [10] Biomarkers of immunotherapy for non-small cell lung cancer
    Shirasawa, Masayuki
    Yoshida, Tatsuya
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (01) : 13 - 22
12345